Physician profile
Daniel Fertel
NPI 1295943793
$1,619.75
in general payments reported to CMS, 2019-2025
16 companies · $457 in 2025
The $457 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $167 · 2020: $126 · 2021: $306 · 2022: $187 · 2023: $377 · 2025: $457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $814 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $813.60 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $441.72 | 2019-2025 | Ofev, Stiolto Respimat |
| Glaxosmithkline, LLC. | $203.38 | 2020-2023 | Nucala, Arexvy |
| Jazz Pharmaceuticals INC. | $173.53 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $147.82 | 2019-2023 | Breztri |
| Grifols USA, LLC | $111.53 | 2019-2023 | Prolastin-C Liquid |
| Mylan Specialty L.P. | $105.80 | 2020-2023 | Yupelri |
| Inari Medical, INC. | $98.69 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Pfizer INC. | $68.68 | 2019-2021 | |
| Csl Behring | $59.10 | 2023 | Kcentra |
| Astellas Pharma US INC | $49.09 | 2021 | |
| Avadel Cns Pharmaceuticals, LLC | $46.83 | 2025 | Lumryz |
| Edwards Lifesciences Corporation | $30.68 | 2023 | Hemosphere |
| Noctrix Health, INC. | $27.81 | 2025 | Nidra |
| Mallinckrodt Hospital Products INC. | $23.09 | 2020 | |
| Pharming Healthcare, INC. | $17.14 | 2023 | Ruconest |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $14.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Fertel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.